Keywords

• Sitagliptinphosphatehydrate(jan) china manufacture
• 7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)Butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazinephosphatemonohydrate china supplier
• Cheap 3(R)-3-amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H [1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one phosphate monohydrate

Quick Details

• ProName: sitagliptin phosphate monohydrate
• CasNo: 654671-77-9
• Molecular Formula: c16h15f6n5o.h3po4.h2o
• Appearance: white crystalline powder
• Application: For pharmaceutical intermediates
• DeliveryTime: Depend on the quantity client want
• PackAge: 0.01-1kg / aluminum foil bag packaging...
• Port: SHANGHAI,CHINA
• ProductionCapacity: 50 Metric Ton/Month
• Purity: 99.0%
• Storage: keep sealed and keep from direct light
• Transportation: by sea/by air/by express
• LimitNum: 10 Gram

Superiority

Product Name: sitagliptin phosphate monohydrate            

Synonyms:Sitagliptinphosphatehydrate(jan);7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)Butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazinephosphatemonohydrate;3(R)-3-amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H [1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one phosphate monohydrate;Sitagliptin phosphate for research;Sitagliptin phosphate hydrate;

(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine dihydrogenphosphate monohydrate;

Sitagliptin phosphate (usan);Januvia (tn);Sitagliptin monohydrate;           

CAS#:654671-77-9            

Molecular formula: c16h15f6n5o.h3po4.h2o            

Molecular weight: 523.33            

Content: ≥ 99.0%            

EE:≥99.0%         

Appearance: white crystalline powder

Package：0.01-1kg / aluminum foil bag packaging, 5kg / cardboard drum or aluminum hall packaging, 25kg / cardboard barrel;

Details

Hangzhou ZeErRui Chemical Co., Ltd. is focused on customization, research and development and production of APIs and advanced intermediates, which can effectively compensate for the deficiencies of traditional CRO and CMO. Priority of high-tech barriers, high value-added, low pollution characteristics of the project, landing the project of innovative non patented route design, difficult process development and rapid industrialization.  Starting from the advantages of combining technology research and stable production, we cooperated with domestic and foreign large pharmaceutical companies in the development of generic drugs and innovative drugs.

It also has hardware facilities and support teams that match the strength of R & D and production: With LCMS, HPLC and other perfect detection means, professional testing team and perfect quality control system; With a pilot base, a stable GMP standard production capacity, and a new GMP workshop is building; With regular financial, legal ERP system and professional sales and logistics team.